Today: 5 February 2026
Subscribe
Browse Category

Analyst Ratings News 21 October 2025 - 11 November 2025

AB InBev (BUD) Today — Nov. 11, 2025: Morgan Stanley Trims Price Target as Buyback Progresses; DZ Bank Reiterates ‘Buy’ and Valuation Debates Heat Up

AB InBev (BUD) Today — Nov. 11, 2025: Morgan Stanley Trims Price Target as Buyback Progresses; DZ Bank Reiterates ‘Buy’ and Valuation Debates Heat Up

Updated: November 11, 2025Tickers: NYSE: BUD · Euronext Brussels: ABI Key points What changed today Morgan Stanley trims but stays bullish. In a Tuesday note, Morgan Stanley reduced its AB InBev price target to $79while maintaining Overweight. The team cut organic volume expectations for FY25 and grew more cautious for early 2026, but nudged FY25 organic EBITDA growth a touch higher after Q3.…
11 November 2025
···
PubMatic (PUBM) Soars on Q3 Beat as Analysts Hike Targets to $20; AI & CTV Momentum in Focus — Nov. 11, 2025

PubMatic (PUBM) Soars on Q3 Beat as Analysts Hike Targets to $20; AI & CTV Momentum in Focus — Nov. 11, 2025

As of 15:42 UTC on Nov. 11, PubMatic shares last traded around $10.40, up sharply intraday following last night’s earnings and a flurry of analyst target increases. Why PUBM is moving today Key numbers & operating highlights Third quarter (ended Sept. 30, 2025): Growth drivers called out by management: Q4 2025 outlook (company guidance) PubMatic guided Q4 revenue to $73M–$77M…
11 November 2025
···
Siemens Energy Hits Record Highs as Analysts Boost Targets: How AI, Grid Demand and a Wind Turnaround Drive the Stock Rally

Siemens Energy Soars After Jefferies Upgrade to €134; Commerzbank Jumps on Deutsche Bank ‘Buy’ as DAX Closes +1.65% (Nov 10, 2025)

Published: Monday, 10 November 2025 German equities rallied to start the week, led by Siemens Energy and Commerzbank after fresh analyst upgrades propelled both stocks to the top of the DAX. The benchmark index finished up 1.65% at 23,959.99, aided by broader risk-on sentiment as investors bet on progress in the U.S. budget impasse. Investing.com Deutsch Key takeaways Siemens Energy…
10 November 2025
···
Qualys (QLYS) Today — Nov 8, 2025: Analyst Upgrade Follows Q3 Beat; Guidance Raised as Stock Hovers Near $150

Qualys (QLYS) Today — Nov 8, 2025: Analyst Upgrade Follows Q3 Beat; Guidance Raised as Stock Hovers Near $150

Qualys, Inc. (NASDAQ: QLYS) is ending the week with fresh analyst attention after posting a stronger‑than‑expected third quarter and raising full‑year guidance earlier this week. As of today, one outlet reports an upgrade to Buy while another highlights lifted EPS forecasts, keeping the cybersecurity name on radar for Google News and Discover readers tracking post‑earnings momentum. The shares are trading…
8 November 2025
····
Breaking: Eos Energy & MN8 Secure Huge 750 MWh U.S. Battery Storage Deal – Are Stocks Set to Skyrocket?

Eos Energy (EOSE) News Today: Price Target Uplift, Fresh Downgrade, and 70% Warrant Surge — What’s Moving the Stock (Nov 8, 2025)

Updated: November 8, 2025 Key takeaways What’s new today (Nov. 8, 2025) Downgrade lands after the run-up. MarketBeat carried an alert that Wall Street Zen cut EOSE to “Sell” early Saturday, noting the stock’s sharp appreciation and summarizing the existing split in coverage (a mix of Buy/Hold/Sell ratings and an average target near the low teens). While not a bulge-bracket…
8 November 2025
···
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth (UNH) Premarket: Analysts Bullish on Comeback Despite 2025 Woes – What to Watch Nov. 3, 2025

UnitedHealth’s volatile 2025 has made UNH a headline story heading into Nov. 3 trading. After a surprise earnings miss in Q1 and a CEO shakeup this spring, UNH plunged to four-year lows. In late Oct. the turnaround narrative got a boost: Q3 beat estimates and management raised guidance Gurufocus Gurufocus. CEO Stephen Hemsley (back at the helm) told investors he’s confident…
2 November 2025
····
Visa (V) Stock Poised for a Surge? Crypto Pilot and Travel Deals Fuel Optimism

Visa Stock Jumps on Earnings Beat and Dividend Hike – Analysts Bullish on $400 Target

Visa’s Stock Rallies After Earnings and Dividend Hike Visa’s latest earnings report delivered plenty for investors to cheer. The company’s fiscal fourth-quarter results (for the quarter ended September 30, 2025) beat expectations on both the top and bottom line. Net revenues grew 12% year-over-year to $10.72 billion, slightly above consensus forecasts around $10.6 billion Timesunion. Adjusted earnings came in at $2.98 per…
28 October 2025
····
Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Shares Triple on Saudi JV News Co-Diagnostics stock exploded higher on Monday, triggered by an unexpected international deal. The small-cap diagnostics firm’s shares opened around $0.59 and skyrocketed, at one point up 133% by mid-morning ts2.tech. The rally accelerated throughout the day – by late morning CODX was +148% and still climbing amid wave after wave of retail buying ts2.tech.…
28 October 2025
···
Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Stock Performance: Clover Health stock has been exceptionally volatile in mid‑October 2025. On Oct. 21 it jumped ~8.7% intraday to ~$3.20 Marketbeat (from $2.92 prior close), and on Oct. 24 it spiked another ~18%, trading near $3.79 (from $3.20 close on Oct. 23) Reuters. According to Reuters data, that surge propelled CLOV close to its 52-week high (~$4.87) and far…
24 October 2025
····
Sunrun (RUN) Stock Soars 5% to 12-Month High on Analyst Upgrades and Solar Incentives

Sunrun (RUN) Stock Soars 5% to 12-Month High on Analyst Upgrades and Solar Incentives

Stock Rallies on Upbeat Sentiment On Oct. 21, 2025, Sunrun (Nasdaq: RUN) traded around $20.50, up about 5% intraday Reuters. This surge followed news that Wall Street’s Citigroup had upgraded Sunrun to “Buy” with a $26 price target Marketbeat. The stock’s rally pushed it above the consensus 12-month analyst target (~$20) ts2.tech. In fact, RUN hit a new 12-month high…
21 October 2025
····
iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

IBIO Stock Price and Recent Volatility As of midday October 21, 2025, iBio’s stock (NASDAQ: IBIO) trades around $0.89 per share Marketbeat. The price has been volatile in recent days. Last week, shares jumped over 20% in pre-market trading on October 17 after Leerink Partners issued a bullish initiation, although the stock later settled near $0.85 by that day’s close…
21 October 2025
···
Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Ticker: Beam Therapeutics (NASDAQ: BEAM) Globenewswire. – Price (Oct 21, 2025): ~$30 per share (about +17% recently) ts2.tech. – Sector: Biotechnology (precision gene editing) Globenewswire. – Recent News: FDA granted Regenerative Medicine Advanced Therapy (RMAT) and Orphan Drug designations to Beam’s lead programs (BEAM-101 for sickle cell disease and BEAM-302 for alpha-1 antitrypsin deficiency) Globenewswire Stocktitan. Early trial data for…
21 October 2025
····
1 … 47 48 49 50

Stock Market Today

  • Investing in TSX Amid Market Rally: Spotlight on 5N Plus and Skeena Resources
    February 5, 2026, 12:17 AM EST. The TSX Composite index continues its strong rally driven by declining interest rates, favourable economic conditions, and robust corporate earnings. Investors remain cautious but opportunities persist for those selective and disciplined. Two standout TSX stocks are 5N Plus (TSX:VNP) and Skeena Resources (TSX:SKE). 5N Plus, a Montréal-based specialty semiconductor producer, has surged nearly 250% in a year, buoyed by demand in clean energy and space technologies. Its Q3 2025 revenue rose 33% year-over-year to US$105 million, with adjusted EBITDA jumping 86%. Meanwhile, Skeena Resources advances its Eskay Creek gold-silver project, attracting capital seeking durable growth in precious metals. These companies exemplify how the TSX rally rewards firms tied to structural growth and hard assets despite concerns of overheating.
Go toTop